Evaluation of Antileishmanial and Antibacterial Activity of Bioconjugate Guanidine–Temporin
Pharmaceuticals · 27.05.2026 · 19 (6) · 835
DOI: 10.3390/ph19060835 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmaceuticals, online erschienen am 27.05.2026. Verfasst von Gabriel Antunes Santoro und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Organic Chemistry, Institute of Chemistry, São Paulo State University (UNESP), Araraquara 14800-060, SP, Brazil. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: São Paulo Research Foundation (FAPESP), Brazil, National Council of Scientific and Technological Development, FINEP.
Abstract (Originalsprache)
Background
Peptides are promising tools in medicine for viral, bacterial, and parasitic infections. MAP1 and MAP2 are peptides with antimicrobial activity. Aiming to increase selectivity, enhance antimicrobial activity, and reduce its cytotoxicity, two bioconjugates (GVL1-MAP2 and GVL1-MAP1) with the guanidine derivative group in the N-terminus position were synthesized.
Methods
The peptides and bioconjugates were synthesized by SPPS. The biological activity and inhibition of the CPB enzyme were evaluated.
Results
Antileishmanial activity was evaluated, and the bioconjugates exhibited higher activity in both the promastigote and amastigote forms than isolated GVL1 and peptides alone.
Discussion
GVL1-MAP2 bioconjugate demonstrated not only the greatest activity against L. amazonensis in the promastigote (IC50 = 3.2 μM) and amastigote (IC50 = 0.6 μM) forms but also prevented the parasite from infecting new host cells, reducing the infection rate by 3-fold compared to the untreated control. Similar results were obtained in L. infantum, with IC50 = 2.5 and 1.0 μM for promastigote and amastigote forms, respectively. In active serum, GVL1-MAP2 continued to show high activity. GVL1-MAP2 also showed bactericidal activity against most strains tested. The bioconjugate GVL1-MAP2 showed lower cytotoxicity than GVL1-MAP1 and amphotericin B in macrophages. Permeabilization studies and enzyme inhibition revealed that the peptide acts via at least two distinct mechanisms, with the primary mechanism targeting the membrane and inner targets as an inhibitor of the CPB enzyme.
Conclusions
These data demonstrated that the synthesis of bioconjugates can be a tool for the development of bactericidal and antileishmanial compounds with improved potency and selectivity.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biochemistry and Organic Chemistry, Institute of Chemistry, São Paulo State University (UNESP), Araraquara 14800-060, SP, Brazil.
- School of Pharmaceutical Sciences, São Paulo State University (UNESP), Araraquara 14800-903, SP, Brazil.
- School of Sciences and Technology, São Paulo State University (UNESP), Presidente Prudente 19060-080, SP, Brazil.
- Department of Physics and Interdisciplinary Science, São Carlos Institute of Physics, University of São Paulo (USP), São Carlos 13563-120, SP, Brazil.
ORCID-Profile: Natalia Caroline Souza Costa, Sarah Tolentino Rocha Brandão, Jhonatan Santos de Lima, Angela Maria Arenas Velasquez, Luana Ribeiro Dos Anjos, Cauã Dias Abrão, Marcela Nunes Argentin, Ilana Lopes Baratella da Cunha Camargo, Marcia A S Graminha, Eduardo Rene P Gonzalez, Eduardo Maffud Cilli
Förderung
- São Paulo Research Foundation (FAPESP), Brazil
- National Council of Scientific and Technological Development
- FINEP
Zitieren
APA
Santoro, G. A., Costa, N. C. S., Brandão, S. T. R., de Lima, J. S., Velasquez, A. M. A., Dos Anjos, L. R., Abrão, C. D., de Souza, J. V. M., Argentin, M. N., Camargo, I. L. B. D. C., Graminha, M. A. S., Gonzalez, E. R. P., & Cilli, E. M. (2026). Evaluation of Antileishmanial and Antibacterial Activity of Bioconjugate Guanidine–Temporin. Pharmaceuticals, 19(6), 835. https://doi.org/10.3390/ph19060835
Vancouver
Santoro GA, Costa NCS, Brandão STR, de Lima JS, Velasquez AMA, Dos Anjos LR, et al. Evaluation of Antileishmanial and Antibacterial Activity of Bioconjugate Guanidine–Temporin. Pharmaceuticals. 2026;19(6):835. doi:10.3390/ph19060835
BibTeX
@article{Santoro2026,
author = {Santoro, Gabriel Antunes and Costa, Natalia Caroline Souza and Brandão, Sarah Tolentino Rocha and de Lima, Jhonatan Santos and Velasquez, Angela Maria Arenas and Dos Anjos, Luana Ribeiro and Abrão, Cauã Dias and de Souza, João Victor Marcelino and Argentin, Marcela Nunes and Camargo, Ilana Lopes Baratella da Cunha and Graminha, Marcia A S and Gonzalez, Eduardo Rene P and Cilli, Eduardo Maffud},
title = {Evaluation of Antileishmanial and Antibacterial Activity of Bioconjugate Guanidine–Temporin},
journal = {Pharmaceuticals},
year = {2026},
volume = {19},
number = {6},
pages = {835},
doi = {10.3390/ph19060835}
}
EUVIMED